Corbus Pharma (CRBP) Lower after Entering Agreement with Cantor on $35M Common Stock Offering

November 23, 2016 6:02 PM EST
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Corbus Pharma (NASDAQ: CRBP) is trading down 6% after-hours after the company disclosed it entered into a Controlled Equity OfferingSM Sales Agreement, or sales agreement, with Cantor Fitzgerald & Co. relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $35.0 million from time to time through Cantor Fitzgerald & Co. acting as sales agent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Related Entities

Cantor Fitzgerald

Add Your Comment